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2ABSTRACT 
Objective:  This study aimed to develop and validate health-related criterion-referenced cut-
points for the modified Canadian Aerobic Fitness Test (mCAFT), a field-based measure to 
predict cardiorespiratory fitness (CRF) among adults (18–69 years). Methods: Criterion-
referenced mCAFT cut-points were developed using nationally representative data from cycles 1 
(2007–09) and 2 (2009–11) of the Canadian Health Measures Survey (CHMS). Receiver 
operating characteristic curves were used to identify age- and sex-specific cut-points for 
measured waist circumference, blood pressure, and high-density lipoprotein. Cut-points were 
validated against metabolic syndrome using a fasted sub-sample (n=1,093) from cycle 5 (2016–
17). Results: 4,967 participants (50% women) were retained for the main analyses. The mCAFT 
cut-points ranged from 28 to 43 mL•kg–1•min–1 (AUC: 0.60-0.87) among men, and 23 to 37 
mL•kg–1•min–1 (AUC: 0.61-0.86) among women. The likelihood of meeting the new mCAFT 
cut-points decreased with an increase in the presence of metabolic risk factors. In total, 54% 
(95%CI: 42 to 67%) of Canadian adults met the new mCAFT cut-points in 2016–17. Conclusion: 
This study developed and validated the first health-related criterion-referenced mCAFT cut-
points for metabolic health among Canadian adults aged 18–69 years. These mCAFT cut-points 
may be useful in health surveillance, clinical, and public health settings.
Novelty bullets
 We developed and validated new criterion-referenced cut-points for the modified 
Canadian Aerobic Fitness Test to help identify adults at potential risk of poor metabolic 
health.
 These new cut-points could help support national health surveillance efforts.
Keywords: Cardiorespiratory fitness, adults, metabolic syndrome, health, surveillance, fitness, 
aerobic evaluation
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3INTRODUCTION
Cardiorespiratory fitness (CRF) represents the ability of the heart, lungs, and muscles to 
deliver oxygen to support muscle movement during physical activity (Ross et al. 2016). CRF is 
partly determined by genetics (30–50%), and primarily modified by physical activity (Bouchard 
and Shephard 1994). CRF is considered an important modifiable trait among adults that is 
negatively associated with a range of chronic health conditions (e.g., cardiovascular diseases, 
diabetes), including metabolic syndrome (Ross et al. 2016; Ford and Li 2008; Katzmarzyk et al. 
2005; Kelley et al. 2018). Further, higher CRF is associated with lower all-cause mortality risk 
(Kodama et al. 2009). Research also suggests that the addition of CRF to traditional risk scores, 
such as the Framingham, substantially improves the net reclassification of patients in clinical 
settings (Ross et al. 2016). For these reasons, the American Heart Association has recommended 
the inclusion of CRF as a clinical vital sign that should be measured in clinical and public health 
settings (Ross et al. 2016). 
CRF can be estimated indirectly using non-exercise equations (Nes et al. 2011; Nes et al. 
2014), questionnaires (Merellano-Navarro et al. 2017), submaximal exercise tests (e.g., 6-minute 
walk test; Enright 2003), or maximal exercise tests (e.g., treadmill running test; Myers et al. 
1991) with or without gas analysis. Although lab-based gas analyzed exercise tests with maximal 
effort are the gold standard assessment of CRF, they are costly and time-consuming making 
them difficult to implement in population-based surveillance. In Canada, nationally 
representative estimates for CRF are predicted using the modified Canadian Aerobic Fitness Test 
(mCAFT) (Weller et al. 1993; Weller et al. 1995), a submaximal test collected through a national 
health survey (Canadian Health Measures Survey [CHMS]).
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4To help establish CRF as a clinical and public health vital sign it is important to identify 
the minimal CRF values (i.e., O2max) associated with low risk for poor health outcomes (e.g., 𝑉
chronic diseases, mortality risk), known as clinical cut-points or thresholds. The two most 
common methods used to establish cut-points include normative- and criterion-referenced (Lang 
et al 2019). Whereas several normative-based cut-points have been proposed (Riebe et al. 2018; 
CSEP 2013; Hoffmann et al. 2019), a limitation of such an approach is that normative cut-points 
are generally not linked to a health-related outcome. There are currently no known health-related 
criterion-referenced cut-points for CRF among adults. The closest health-related cut-points (i.e., 
linked to risk of mortality and cardiovascular events) for the general population were proposed 
through a comprehensive meta-analysis that suggested O2max values for men and women aged 𝑉
40–60 years should be greater than 25 to 32 mL•kg–1•min–1 and 18 to 25 mL•kg–1•min–1, 
respectively, depending on age groups (Kodama et al. 2009). 
This paper was organized into two phases that correspond to the datasets that were 
analyzed. The objective of phase one was to establish age- and sex-specific health-related 
criterion-referenced cut-points for the mCAFT among Canadian adults aged 18–69 years using 
CHMS data from 2007–11 (cycles 1 and 2). The objective of phase two was to validate the 
established mCAFT cut-points against metabolic syndrome in an independent sub-sample of 
fasted participants from the CHMS, 2016–17 (cycle 5). The secondary objective of phase two 
was to calculate the prevalence of Canadian adults that met the new mCAFT cut-points in an 
independent sub-sample of non-fasted participants from the CHMS, 2016–17 (cycle 5).  
MATERIALS AND METHODS 
Participants
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5To establish age- and sex-specific mCAFT cut-points (phase 1) we obtained data from 
4,967 participants aged 18–69 years (50.4% women; mean age, 95% confidence interval: 40.5 
years [40.0, 41.0]) from cycles 1 (2007–09) and cycle 2 (2009–11) of the CHMS. As part of 
phase two, we analyzed CHMS cycle 5 data (2016-17) in two sub-samples: fasted and non-
fasted. Within each dwelling, participants were randomly assigned to the fasted or non-fasted 
sample. The sampling fractions were adjusted to obtain approximately half of the sample fasted 
(Statistics Canada 2013a, 2013b). To validate the new cut-points, we analyzed the subsample of 
1,093 fasted participants from cycle 5 (51.0% women; mean age, 95% confidence interval: 43.0 
years [42.0, 44.1]). To calculate the prevalence of Canadian adults meeting the new mCAFT cut-
points, we analyzed a subsample of 1,094 non-fasted participants from cycle 5(50.3% women; 
mean age, 95% confidence interval: 40.7 years [39.1, 42.2]). Details on sampling, data 
collection, and the measures included in the CHMS are described in detail elsewhere (Statistics 
Canada 2013a, 2013b; Tremblay et al. 207; Tremblay et al. 2010). Briefly, the CHMS is a 
nationally representative, cross-sectional survey used to collect objectively measured health data 
from Canadians aged 3–79 years. Approximately 96% of Canadians are represented in the 
CHMS, with those from the three territories, Aboriginal settlements, members of the Canadian 
Forces, institutionalized individuals, and those living in certain rural areas excluded from the 
survey. Data collection for the CHMS took place in two steps: first, participants provided 
demographic and self-reported information during an interview conducted at the participant’s 
household; next, participants attended a mobile examination centre to collect direct health 
measures. The overall response rate for cycles 1 and 2 was 54% and 49% for cycle 5 (Statistics 
Canada 2013a, 2013b, 2019). Bootstrap and sample weights were used to account for the 
complex survey design and non-response bias. The CHMS was approved by the Health Canada 
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6Research Ethics Board (Day et al. 2007). All participants provided written, informed consent 
prior to participating in the survey.
Modified Canadian Aerobic Fitness Test
Trained health specialists assessed CRF using the mCAFT — a progressive submaximal 
step test. The mCAFT was assessed following the Canadian Physical Activity, Fitness and 
Lifestyle Approach protocol (CSEP 2003). Details on the mCAFT can be found elsewhere (Craig 
et al. 2012). Briefly, participants followed an age- and sex-specific cadence that increased every 
three minutes. The test was terminated when a participant’s heart rate reached 85% of their age-
predicted maximal heart rate (220 – age) at the end of the stage (Fox and Naughton 1972). 
Participants were also able to terminate the test if they could not complete a full 3-minute stage. 
The mCAFT has very strong criterion validity against gas-analyzed O2max (r=0.88) in 𝑉
Canadians aged 15–69 years (Weller et al. 1993, 1995). Participant’s O2max (mL•kg–1•min–1) 𝑉
was estimated using the following prediction equation: 
Predicted O2max = 17.2 + (1.29 * O2) – (0.09 * mass) – (0.18 * age)𝑉 𝑉
where O2 is the oxygen cost in mL•kg–1•min–1of the final completed stage, mass is in kilograms, 𝑉
and age is age in years at last birthday (CSEP 2003; Weller 1989). 
Phase one, establishing criterion-referenced cut-points 
Three criterion health measures (waist circumference, blood pressure, and high-density 
lipoprotein [HDL] cholesterol) were assessed by trained health specialists. The criterion health 
measures used to calculate the mCAFT cut-points were obtained from cycles 1 and 2 (2007–11) 
of the CHMS. Waist circumference was measured at the midpoint between the lowest floating rib 
and the top of the iliac crest following the World Health Organization protocol (World Health 
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7Organization 2008). Waist circumference thresholds to identify abdominal obesity were based on 
the values recommended as part of the harmonized metabolic syndrome statement that 
recommends population or ethnicity specific thresholds (Alberti et al. 2008). Systolic and 
diastolic blood pressure were measured using the CHMS protocol which allows for five minutes 
of quiet rest followed by six measurements at 1-minute intervals using an automated oscillometer 
2(BpTRUTM BPM-300, BpTRUTM Medical Devices Ltd., Coquitlam, British Columbia) (Paradis 
et al. 2010; Joffres et al. 2013; Wilkins et al. 2010). The mean resting blood pressure was 
calculated from the final five measurements. Blood pressure was classified as high following the 
harmonized metabolic syndrome statement (systolic ≥130 and/or diastolic ≥85 mmHg) (Alberti 
et al. 2008). Self-reported anti-hypertension medication was also used to classify individuals 
with elevated blood pressure. HDL cholesterol was measured in serum from non-fasted blood 
samples. Low HDL cholesterol was classified following the harmonized metabolic syndrome 
statement (<1.0 mmol/L for men and <1.3 mmol/L for women) ((Alberti et al. 2008). 
Participants who self-reported using bile acid sequestrants were also classified as having low 
HDL cholesterol. Blood samples were collected by certified phlebotomists and analyzed at the 
Health Canada laboratory following standardized procedures (Bryan et al. 2007). 
Phase two, validation against metabolic syndrome
A sub-sample of participants who took part in cycle 5 (2016–17) of the CHMS were 
randomly flagged and asked to fast for 10 hours prior to data collection (Statistics Canada 2019). 
This sub-sample participated in the full CHMS measurement protocol in addition to providing 
fasting blood samples to measure triglycerides and glucose levels. Certified phlebotomists 
collected all blood samples which were analyzed at the Health Canada laboratory following 
standard procedures (Bryan et al. 2007). More details about the sampling, storage, and analyses 
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8of bio-specimens from the CHMS are reported elsewhere (Bryan et al. 2007). Metabolic 
syndrome was defined using the harmonized metabolic syndrome statement which was 
operationalized as meeting at least three of the following risk factors: elevated waist 
circumference (using population or ethnicity specific thresholds); elevated triglycerides (≥1.7 
mmol/L); low HDL (<1.0 mmol/L for men and <1.3 mmol/L for women); elevated blood 
pressure; elevated fasting glucose (≥5.5 mmol/L) (Alberti et al. 2008).  Self-reported medication 
use for problematic triglycerides, cholesterol, blood pressure, and/or glucose was also used to 
classify individuals as having the related risk factor (Alberti et al. 2008). The fasted sub-sample 
was used to cross-validate the established mCAFT cut-points by describing the ability to 
discriminate individuals across stratums of metabolic syndrome risk factors. 
Phase two, prevalence meeting the new mCAFT cut-points
A non-fasted subsample of from cycle 5 the CHMS (2016–17) was used to calculate the 
prevalence of Canadian adults meeting the new mCAFT cut points. All participants with a valid 
mCAFT score were included in the prevalence analysis. 
Statistical analyses
Analyses were conducted using the Statistical Analysis System Enterprise Guide (SAS 
EG; version 5.1). Statistical significance was set at p<0.05. Descriptive statistics were calculated 
for all study variables as means or proportions with 95% confidence intervals. 
Phase one analysis. Receiver operating characteristic (ROC) curve analyses were used to 
identify mCAFT cut-points to help detect individuals at increased metabolic risk across age- and 
sex-specific groups. Metabolic risk was operationalized using waist circumference, blood 
pressure, and HDL cholesterol. ROC curve values were plotted as sensitivity and specificity for 
each potential cut-point value. Sensitivity (or true positive rate) represents the proportion of the 
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9sample correctly identified as metabolically unhealthy, and specificity (or true negative rate) 
represents the proportion of the sample correctly identified as metabolically healthy. Cut-points 
that optimized both sensitivity and specificity were selected (i.e., Youden’s J) (Fluss et al. 2005). 
The area under the curve (AUC) was calculated as a summary statistic that represents the 
discriminatory ability of the mCAFT. An AUC value of 1 represents a perfect discriminatory 
ability, a value of 0.5 represents no discriminatory ability, and AUC values of 0.55–0.62, 0.63–
0.71 and >0.71 represent weak, moderate, and strong effect sizes, respectively (Rice et al. 2005). 
ROC curve analyses were conducted for waist circumference, blood pressure, and HDL 
cholesterol, separately for each sex and the three age groups (18–34, 35–54, and 55–69). The 
mean mCAFT cut-point across all three measures was selected as the recommended cut-points 
for each age and sex specific group. More details on ROC curves using complex survey data are 
provided elsewhere (Lang et al. 2020; Agnelli 2014). 
Phase two, validation analysis. Stratum-specific likelihood ratios were calculated to 
evaluate the accuracy of the new mCAFT cut-points in classifying individuals across metabolic 
syndrome risk factor strata (0–2 indicators, 3 indicators, and 4–5 indicators) (Peirce et al. 1993; 
Schmitz et al. 2000). Within each metabolic syndrome category (stratum), the ratio of individuals 
meeting versus not meeting the new mCAFT cut-points were calculated (Peirce et al. 1993). A 
stratum-specific likelihood ratio of ≥5 suggests that individuals within a stratum are highly 
unlikely to meet the new cut-points, whereas a stratum-specific likelihood ratio of <0.1 indicates 
that individuals in a stratum are highly likely to meet the cut-point (Feng et al. 2009). It was 
anticipated that the stratum-specific likelihood ratios would increase with an increase in the 
number of metabolic syndrome risk factors across strata. 
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10
Phase two, prevalence analysis. Following the validation analyses, the prevalence of 
Canadian adults meeting the new mCAFT cut-points in 2016–17 (CHMS cycle 5) was calculated 
using survey and bootstrap weights. 
RESULTS
Descriptive statistics for the phase one sample (cycles 1 and 2), the phase two validation 
sub-sample (cycle 5 fasted sub-sample) and the phase two prevalence sub-sample (cycle 5 non-
fasted sample) are presented in Table 1. Among the phase one sample (2007–11), mean CRF was 
16% higher among men (39.2 mL•kg–1•min–1) than women (33.7 mL•kg–1•min–1). Among men 
and women, respectively, approximately 27% and 36% had an elevated waist circumference, 
23% and 31% had low HDL, and 18% and 9% had elevated blood pressure. The values for the 
phase one sample were not substantially different from the values in the phase two sub-samples. 
The ROC curve generated mCAFT cut-points, sensitivity, specificity, positive and 
negative predictive values for each age by sex group are presented in Table 2, representing phase 
one of this study. The average mCAFT cut-points associated with high metabolic risk were 42.7 
mL•kg–1•min–1 for younger men (18–34 years), 38.5 mL•kg–1•min–1 for middle-aged men (35–54 
years), and 27.9 mL•kg–1•min–1 for older men (55–69 years). Among women, the mCAFT cut-
points associated with metabolic syndrome were 37.0 mL•kg–1•min–1 for younger women (18–34 
years), 33.6 mL•kg–1•min–1 for middle-aged women (35–54 years), and 23.2 mL•kg–1•min–1 for 
older women (55–69 years). ROC curves including AUC values across age and sex groups are 
presented in Figure 1 for men and Figure 2 for women. The AUC values ranged from 0.60 to 
0.87 and 0.61 to 0.86 for men and women, respectively. All of the ROC curves demonstrated 
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acceptable AUC values (all values >0.6), representing moderate predictive power for the 
mCAFT to discriminate those with or without an existing metabolic risk factor.
The stratum-specific likelihood ratios calculated in the validation sub-sample (phase two) 
ranged from 0.75 to 12.59 and increased with each subsequent increase in metabolic syndrome 
stratum (Table 3). The stratum-specific likelihood ratios were <1 for adults with 0–2 existing 
metabolic syndrome risk factors (indicators). For individuals with 3 existing metabolic syndrome 
risk factors (indicators) stratum-specific likelihood ratios values were 3.0 and 4.5 for men and 
women, respectively. Among individuals with 4–5 existing metabolic syndrome risk factors 
(indicators), the stratum-specific likelihood ratios were 6.2 and 12.5 for men and women, 
respectively. 
In phase two, 54% (95%CI: 43 to 65%) of men and women met the new mCAFT cut-
points, with the prevalence of men being slightly higher than women (54% [95%CI: 42 to 67%]). 
Among men, 74% (95%CI: 61 to 86%) of younger, 41% (95%CI: 29 to 53%) of middle-aged, 
and 48% (95%CI: 33 to 63%) of older men met the mCAFT cut-points. Among women, 61% 
(95%CI: 41 to 80%) of younger, 47% (95%CI: 33 to 60%) of middle-aged, and 56% (95%CI: 37 
to 74%) of older women met the mCAFT cut-points (Supplementary Figure S1). 
DISCUSSION 
This study represents a large effort to produce the first data driven age- and sex-specific 
mCAFT cut-points to help identify individuals at risk of poor metabolic health. To our 
knowledge, these are the first cut-points to be validated against objectively measured metabolic 
syndrome among adults. They also help support a growing body of literature on criterion-
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referenced cut-points for healthy CRF that have largely been focused in paediatric populations 
(Lang et al. 2019). The new mCAFT cut-points ranged from 27.9 mL•kg–1•min–1 to 42.7 mL•kg–
1•min–1 among men, and from 23.2 mL•kg–1•min–1 to 37.0 mL•kg–1•min–1 among women. These 
cut-points are higher than values reported elsewhere using different CRF measures (discussed in 
detail below) (Kodama et al. 2009). Individuals were increasingly less likely to meet the new 
mCAFT cut-points as the number of existing metabolic syndrome risk factors increased. Women 
were almost twice as likely as men to not meet the new cut-points when ≥4 risk factors were 
present. AUC values were highest for waist circumference compared to HDL and blood pressure, 
which suggests that the mCAFT is better at discriminating individuals with high waist 
circumference. 
To our knowledge, there are no published health-related criterion-referenced mCAFT 
cut-points for adults, although normative based cut-points using a quintile framework have been 
proposed for the mCAFT by the Canadian Society for Exercise Physiology (CSEP 2013). The 
CSEP Health Benefit Rating Zones have been used categorize CRF as poor, fair, good, very 
good, or excellent based on age- and sex-specific centile distributions (CSEP 2013; Shields et al. 
2010). The new mCAFT cut-points fall within the poor, fair, or good zones with no apparent sex- 
or age-specific patterns emerging. The CSEP Health Benefit Rating Zones were not tied to a 
health-related outcome, suggesting that an individual’s mCAFT score may be considered as poor 
or fair based on the Health Benefit Rating Zones despite being above the new health-related CRF 
cut-points. 
Our mCAFT cut-points are higher across all age and sex groups when compared to those 
proposed by Kodama et al (2009). These differences may be partially explained by the variety of 
CRF assessments included in the meta-analysis (e.g., treadmill, cycle ergometer) and the 
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inclusion of maximal and submaximal working capacity tests. Further, Kaminsky et al (2015), 
developed referenced-based CRF cut-points using cardiopulmonary exercise testing (a direct 
measure of O2 max) in adults from the United States. Reference values are presented for men and 𝑉
women in 10-year age groups (e.g., 20–29, 30–39 year olds etc.), whereas we presented our 
results by younger (18–34 years), middle-aged (35–54 years), and older (55–69 years) age 
groups. Despite differences in age groups and CRF fitness testing methods, recommended values 
were similar across different age and sex groups. The mCAFT cut-points were approximately 4.7 
to 5.7 mL•kg–1•min–1 lower among women compared to men, which is similar to Kaminsky et al 
(2015). 
As anticipated, our mCAFT cut-points decreased with age. For example, the cut-points 
decreased by 10% (men) and 9% (women) between young and middle adulthood, and by 28% 
(men) and 31% (women) between middle and older adulthood. Although evidence supports the 
declines in CRF with age, the age-related change in criterion-referenced CRF cut-points for 
metabolic risk has been sparsely investigated in the literature and represents an area of future 
research (Kminsky et al. 2015). 
Our validation analyses support the notion that those who have metabolic syndrome are 
more likely to not meet the new mCAFT cut-points. The likelihood of not meeting the new cut-
points was much higher for those with ≥4 metabolic risk factors present, compared to those with 
≤3 metabolic risk factors. Among those with ≥4 existing risk factors, women were almost twice 
as likely to not meet the new cut-points. Given that the current guidelines for the classification of 
metabolic syndrome are the presence of ≥3 risk factors, there may be value in assessing 
metabolic syndrome in relation to the mCAFT based on the number and type of indicators 
present (Alberti et al. 2009). 
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Among individuals who participated in cycle 5 (2016–17) of the CHMS, 54% of 
Canadian adults met the mCAFT cut-points. These values are low considering the fact that only 
15% and 19% of men and women, respectively, were classified as having metabolic syndrome in 
2016–17. This suggests that our mCAFT cut-points are conservative and should not be used to 
diagnose metabolic syndrome. Rather, these cut-points should be used to screen individuals at 
increased risk of metabolic syndrome and in need of a more thorough examination. This cost-
effective, non-invasive approach could help save considerable time in clinical settings. While the 
proportion of adults meeting the mCAFT cut-points decreased as expected from young to middle 
adulthood, the proportion increased from middle to older adulthood. This was unexpected given 
the results from the analytical sample. There are several possible explanations for this result, 
including a healthy volunteer effect where individuals who were healthy were potentially more 
likely to participate in the survey, an effect that may have been more evident in older adults. 
There also may have been a selection bias as a result of rigorous inclusion/exclusion criteria. 
Conversely, it could be that the mCAFT cut-points for older adults are easier to attain and result 
in slightly higher proportions meeting the cut-points in comparison with their middle-aged 
counterparts. 
Strengths and limitations
Strengths of the present study include a large, nationally representative sample, the use of 
an objective measure to estimate CRF (mCAFT), and directly-measured metabolic syndrome risk 
factors classified using the harmonized statement on metabolic syndrome (Alberti et al. 2008). 
The use of ROC curves to derive health-related criterion-referenced cut-points and the inclusion 
of an independent validation sub-sample are also strengths. Other strengths include the use of 
survey and bootstrap weights to account for non-response and the complex survey design. 
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Despite these strengths, there were several limitations. For instance, we used cross-
sectional data which precludes causal relationships. As CRF data were collected using the 
mCAFT, cut-points should not be applied to other measures of CRF or other populations without 
proper investigation. Given the higher respondent burden to collect fasting blood work, glucose 
and triglyceride levels are not available for the entire CHMS sample, hindering the ability to use 
all five indicators of metabolic syndrome in the initial identification of the cut-points. The 95% 
confidence intervals were not calculated for the AUC, sensitivity, and specificity as the survey 
and bootstrap weights could not be integrated in the ROC curve calculations. The strict inclusion 
criteria for participation in the mCAFT may have biased our results towards a healthier and fitter 
sample by excluding individuals based the Physical Activity Readiness Questionnaire (PAR-Q) 
and/or other exclusion criteria (e.g., elevated resting heart rate or blood pressure values, 
difficulty breathing at rest) (Statistics Canada 2013b). Previous studies have showed that those 
excluded from the mCAFT in the CHMS typically had a higher body mass index when compared 
with those who were included in the mCAFT (Shields et al. 2010). The health-related nature of 
the study may have also created a higher rate of non-response for those who were unhealthy. 
This scenario was partially tested by comparing body mass index values between the CHMS and 
the Canadian Community Health Survey (a general health survey), with results indicating a 
negligible difference between the surveys (Shields et al. 2010). This suggested that, at least for 
body mass index, the nature of the CHMS did not have an impact on survey estimates.  
Conclusions and future directions
This study developed and validated the first health-related criterion-referenced mCAFT 
cut-points for metabolic health among Canadian adults aged 18–69 years. These findings can 
help support the classification of potentially at-risk individuals using the mCAFT in both clinical 
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and public health settings. From a practical perspective, implementing field-based measurements 
of CRF, such as the mCAFT, is often more feasible and cost-effective when compared to 
assessing biomarkers through blood samples. These findings can also help advance CRF as a 
clinical vital sign, as proposed by the American Heart Association (Ross et al. 2016). Future 
research should validate the mCAFT cut-points using other field-based or lab-based measures of 
CRF to increase their clinical, health surveillance, and public health applicability. 
Conflict of interest: The authors have no conflicts of interest to report.
Disclaimer: The content and views expressed in this article are those of the authors and do not 
necessarily reflect those of the Government of Canada.
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1 Table 1. Descriptive statistics for Canadian adults aged 18–69 years
Characteristics 
Mean/% (95%CI)
Phase one sample 
2007–11, n=4,967
Phase two validation sample 
2016–17, n=1,093
Phase two prevalence sample 
2016–17, n=1,094
Men Women Men Women Men Women
Sex, % 50.4 (49.3, 51.6) 49.7 (48.4, 50.7) 49.0 (45.2, 52.7) 51.0 (47.3, 54.8) 49.7 (45.0, 54.4) 50.3 (45.6, 55.0)
Age, %
18–34 years      38.0 (35.3, 40.7) 35.4 (33.2, 37.6) 31.5 (27.1, 36.0) 33.8 (26.1, 41.4) 36.6 (29.3, 43.9) 41.4 (34.6, 48.2)
35–54 years 45.8  (42.7, 49.0) 45.8 (43.2, 48.4) 45.8 (37.6, 54.0) 38.8 (30.9, 46.7) 42.6 (34.7, 50.5) 40.2 (33.0, 47.4)
55–69 years 16.2 (14.1, 18.3) 18.8 (16.6, 21.1) 22.7 (16.1, 29.3) 27.4 (22.7, 32.1) 20.8 (15.9, 25.7) 18.4 (12.9, 23.9)
Household education, %
Less than college 17.9 (14.8, 21.0) 19.2 (15.0, 23.3) 29.2 (20.2, 38.4) 24.2 (18.3, 30.1) 22.1 (13.8, 30.4) 20.2 (14.1, 26.3)
College 33.9 (27.8, 40.0) 37.2 (32.8, 41.6) 22.6 (17.4, 27.8) 21.5 (14.0, 28.9) 23.1 (13.5, 32.7) 30.5 (22.9, 38.0)
University 48.2 (40.3, 56.0) 43.6 (37.6, 49.7) 48.1 (39.1, 57.1) 54.3 (45.4, 63.1) 54.8 (47.6, 62.0) 49.4 (37.2, 59.5)
mCAFT CRF, 
O2max, mL•kg–1•min–1𝑉 39.2 (38.5, 40.0) 33.7 (33.3, 34.2) 36.6 (35.3, 38.1) 31.3 (29.9, 32.7) 38.1 (36.9, 39.3) 33.7 (32.5, 35.0)
Waist circumference, cm
Waist circumference 93.1 (92.0, 94.3) 84.3 (83.0, 85.6) 93.9 (90.8, 97.0) 88.2 (85.2, 91.2) 94.7 (92.6, 96.8) 85.4 (82.4, 88.4)
Elevated waist circumference, % 27.2 (23.4, 30.9) 35.6 (31.9, 39.3) 23.6 (16.4, 30.1) 45.3 (38.5, 52.2) 29.7 (22.4, 37.0) 33.4 (24.4, 42.4)
HDL, mmol/L
HDL 1.2 (1.2, 1.3) 1.5 (1.5, 1.6) 1.3 (1.2, 1.3) 1.7 (1.6, 1.8) 1.2 (1.2, 1.3) 1.6 (1.6, 1.7)
Reduced HDL, % 22.9 (18.5, 27.4) 31.1 (25.8, 36.4) 19.7 (13.4, 26.0) 22.6 (17.0, 28.2) 28.9 (21.3, 36.5) 27.1 (21.4, 32.9)
Systolic Blood Pressure, 
mmHg
Systolic blood pressure 112.3 (111.2, 
113.4)
105.8 (104.7, 
106.9)
112.0 (110.7, 
113.3)
110.0 (107.0, 
112.9)
111.9 (110.5, 
113.3)
107.2 (105.3, 
109.1)
Diastolic blood pressure 73.4 (72.6, 74.2) 68.5 (67.8, 69.2) 73.3 (72.4, 74.2) 71.0 (69.7, 72.3) 72.2 (70.7, 73.7) 69.8 (68.4, 71.3)
Elevated blood pressure, % 17.5 (14.3, 20.7) 9.1 (7.0, 11.2) 20.9 (17.1, 24.6) 15.7 (8.4, 23.1) 16.2 (10.0, 22.4) 12.8 (7.9, 17.6)
Triglycerides, mmol/L
Triglycerides - - 1.4 (1.3, 1.5) 1.2 (1.1, 1.3) - -
Elevated triglycerides, % - - 24.2 (17.4, 30.9) 16.3 (11.5, 21.0) - -
Fasting glucose, mmol/L
Fasting glucose - - 5.5 (5.4, 5.6) 5.2 (5.0, 5.4) - -
Elevated fasting glucose, % - - 28.8 (23.6, 34.1) 15.8 (8.5, 23.1) - -
Metabolic syndrome, %
Metabolic syndrome - - 14.6 (9.6, 19.5) 18.1 (11.2, 25.1) - -
2 Note: 95% CI=95% confidence interval; CRF=cardiorespiratory fitness; mCAFT= modified Canadian Aerobic Fitness Test; O2max=maximum oxygen uptake 𝑉
3 in mL/kg/min; HDL= high density lipoprotein; mmol/L= millimoles per litre; mmHg=millimeters of mercury.
4 Source: 2007-2009 and 2009-2011 (cycles 1 and 2) of the Canadian Health Measures Survey, combined; cycle 5 (2016-2017) of the Canadian Health Measures 
5 Survey (Statistics Canada 2013a; Statistics Canada 2013b; Statistics Canada 2019).
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Table 2. Receiver operating characteristic curves to establish optimal outcome-specific mCAFT cut-points for young, middle-aged, 
and older adults. Mean values represent the recommended mCAFT cut-point for each age group.
O2 max𝑉
(mL•kg–1•min–1)
Sensitivity (%) Specificity (%) PPV (%) NPV (%)
Younger men (18–34 years)
Elevated WC 42.0 78.7 83.1 45.9 95.6
Elevated BP 44.2 77.3 60.8 100.0 97.9
Low HDL 41.8 44.3 80.8 38.1 84.4
Mean O2 max (SD) 𝑉 42.7 (1.3)
Middle-aged men (35–54 years)
Elevated WC 39.3 82.4 62.3 51.0 88.1
Elevated BP 38.9 67.6 54.4 23.3 89.2
Low HDL 37.4 58.4 63.6 34.2 82.6
Mean O2 max (SD) 𝑉 38.5 (1.0)
Older men (55–69 years)
Elevated WC 26.5 61.8 81.4 66.2 78.4
Elevated BP 29.7 74.5 45.7 44.7 75.3
Low HDL 27.6 60.5 59.9 26.5 86.3
Mean O2 max (SD) 𝑉 27.9 (1.6)
Young women (18–34 years
Elevated WC 37.1 73.9 82.0 58.4 90.2
Elevated BP 36.6 70.6 73.6 4.9 99.2
Low HDL 37.3 47.6 71.4 46.7 72.1
Mean O2 max (SD) 𝑉 37.0 (0.4)
Middle-aged women (35–54 years)
Elevated WC 34.2 82.2 62.7 57.5 85.1
Elevated BP 31.4 61.9 68.8 15.9 95.0
Low HDL 35.1 72.6 43.9 38.3 77.0
Mean O2 max (SD) 𝑉 33.6 (1.9)
Older women (55–69 years)
Elevated WC 23.1 66.4 81.3 78.2 70.5
Elevated BP 23.7 66.2 58.1 38.2 81.4
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Low HDL 22.7 52.9 66.7 32.3 82.5
Mean O2 max (SD) 𝑉 23.2 (0.5)
WC=waist circumference; BP=blood pressure; HDL=high density lipoprotein; SD=standard deviation; PPV = positive predictive value; NPV = negative 
predictive value
Data source: 2007-2009 and 2009-2011 (cycles 1 and 2) of the Canadian Health Measures Survey, combined (Statistics Canada 2013a; Statistics Canada 
2013b).
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Table 3. Stratum-specific likelihood ratios used to validate the established mCAFT cut-points 
across strata (categories) of metabolic syndrome risk factors for men and women, separately. 
0–2 risk factors 3 risk factors 4–5 risk factors
SSLR  95% CI SSLR 95% CI SSLR 95% CI
Men 0.75  (0.69, 0.82) 3.26  (1.78, 5.97) 6.64  (2.65, 16.39)
Women 0.79  (0.73, 0.84) 4.26  (2.04, 8.91) 12.59  (3.04, 52.07)
Note: Three or more risk factors present was used to identify individuals with metabolic 
syndrome. SSLR = stratum-specific likelihood ratios; 95% CI=95% confidence interval
Data source: cycle 5 (2016-2017) of the Canadian Health Measures Survey (Statistics Canada 2019).
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FIGURE CAPTIONS
Figure 1. Receiver Operating Characteristic curves plotting sensitivity and 1–specificity for 
Canadian men by age group for blood pressure, high-density lipoprotein, and waist 
circumference. Data source: Canadian Health Measures Survey cycles 1 and 2 (2007–11).  
BP=blood pressure; HDL=high-density lipoprotein; WC=waist circumference; AUC=area under 
the curve (Statistics Canada 2013a; Statistics Canada 2013b)
Figure 2. Receiver Operating Characteristic curves plotting sensitivity and 1–specificity for 
Canadian women by age group for blood pressure, high-density lipoprotein, and waist 
circumference. Data source: Canadian Health Measures Survey cycles 1 and 2 (2007–11).  
BP=blood pressure; HDL=high-density lipoprotein; WC=waist circumference; AUC=area under 
the curve (Statistics Canada 2013a; Statistics Canada 2013b)
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 Figure 1
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Figure 2
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